AstraZeneca

AstraZeneca’s TAGRISSO Combo Shows Strong Survival Benefit in EGFR-Mutated Lung Cancer

WILMINGTON, DE — AstraZeneca announced that its lung cancer therapy TAGRISSO® (osimertinib), when used in combination with chemotherapy, delivered a statistically significant and clinically meaningful improvement in overall survival for patients …

AstraZeneca’s TAGRISSO Combo Shows Strong Survival Benefit in EGFR-Mutated Lung Cancer Read More



#1 - Radon is a Spooky Thing

Is Your Home Safe? Pennsylvania Urges Action Against Deadly Radon as Young Artists Lead the Fight

HARRISBURG, PA — The Pennsylvania Department of Environmental Protection (DEP) recently announced the winners of the 2025 Pennsylvania Student Radon Poster Contest while continuing its educational campaign urging residents to …

Is Your Home Safe? Pennsylvania Urges Action Against Deadly Radon as Young Artists Lead the Fight Read More

Molecular Targeting Technologies

Promising New Radiopharmaceutical Shows Breakthrough Potential in Cancer Treatment

WEST CHESTER, PA — Molecular Targeting Technologies, Inc. (MTTI) has unveiled significant preclinical results for its proprietary Ac-EBTATE radiopharmaceutical, demonstrating remarkable efficacy against somatostatin receptor-2-positive neuroendocrine tumors (NETs), including small …

Promising New Radiopharmaceutical Shows Breakthrough Potential in Cancer Treatment Read More
A doctor holding an x ray result

Pennsylvania’s Battle with Lung Cancer: Progress Unveiled, Challenges Persist in 2024 Report

HARRISBURG, PA — The American Lung Association‘s 2024 “State of Lung Cancer” report brings a mixed bag of findings for Pennsylvania, revealing both significant strides and critical areas needing attention in …

Pennsylvania’s Battle with Lung Cancer: Progress Unveiled, Challenges Persist in 2024 Report Read More